United States · FDA National Drug Code directory

Myoview

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
17156-026_3475dd6d-4e62-4907-9c45-00845816577f
Product NDC
17156-026
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
Tetrofosmin
Labeler
Medi-Physics Inc. dba GE Healthcare
Marketing category
NDA
Marketing start / end (source format)
20090226
Source listing expiry
20261231

Source-listed ingredients

  • TETROFOSMIN — 1.38 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 VIAL in 1 KIT (17156-026-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 17156-026-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →